Product Program year 2025 Source: CMS Open Payments

Amplatzer Talisman

Device Structural Heart

PDI 05415067033345

Open in the dashboard

General payments

$808,259

3,106 payments

Research payments

$3,299,756

1,640 payments

Through program year 2025, $808,259 in general payments and $3,299,756 in research payments were reported against Amplatzer Talisman (Structural Heart).

No combined total These are different kinds of money, reported under different rules. A meal and a clinical trial grant do not add up to anything meaningful, so this site does not add them.

By program year

8 rows
Year Kind Amount Payments
2025 General $223,307 771
2025 Research $563,419 285
2024 General $235,312 1,034
2024 Research $816,418 352
2023 General $335,045 1,270
2023 Research $950,837 451
2022 General $14,596 31
2022 Research $969,082 552

Breakdown

Who paid General payments · program years 2022–2025
  1. Abbott Laboratories $808,259 3,106 payments
Top recipients General payments · program year 2025
  1. Mark Gajjar Interventional Cardiology · Kyle, TX $28,991 13% · 28 payments
  2. Samuel Turner Interventional Cardiology · Winston Salem, NC $18,239 8% · 27 payments
  3. Daniel Levi Pediatric Cardiology · Los Angeles, CA $9,036 4% · 13 payments
  4. Dhaval Parekh Interventional Cardiology · Houston, TX $9,002 4% · 4 payments
  5. John Lasala Interventional Cardiology · Saint Louis, MO $8,592 4% · 8 payments

The top 5 of the 100 largest recipients; each share is of general payments naming this product in 2025.

The top 25 recipients, free in the app

Specialties paid General payments · program year 2025
  1. Interventional Cardiology Internal Medicine $109,827 49% · 147 practitioners
  2. Pediatric Cardiology Pediatrics $41,741 19% · 8 practitioners
  3. Cardiovascular Disease Internal Medicine $14,559 7% · 67 practitioners
  4. Clinical Cardiac Electrophysiology Internal Medicine $10,285 5% · 21 practitioners
  5. Adult Congenital Heart Disease Internal Medicine $7,713 3% · 2 practitioners

The top 5 of 42 specialties; each share is of general payments naming this product to practitioners with a specialty in 2025. Each practitioner is counted under their primary specialty.

The top 25 specialties, free in the app

Where the money went General payments · program year 2025
  1. Texas $38,737 17% · 16 recipients
  2. California $26,191 12% · 59 recipients
  3. North Carolina $22,571 10% · 20 recipients
  4. Missouri $18,282 8% · 29 recipients
  5. New York $17,617 8% · 29 recipients

The top 5 of 42 states; each share is of general payments naming this product in 2025 where a state was reported.

The top 25 states, free in the app

3,106 general · 1,640 research

Every payment, record by record

Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.

What you are looking at

Manufacturers name the drug, biological or device a payment relates to. CMS does not give products their own identifiers, so a product here is assembled from how it was reported — a brand may appear under more than one spelling, and this page covers one of them rather than the brand as a whole.

Provenance

Source: CMS Open Payments · through program year 2025

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record